Related Experiment Video

Updated: Jun 6, 2026

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
09:52

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

Atherosclerosis, inflammation and Chlamydia pneumoniae

Giovanni Fazio1, Maria Giovino, Alessandro Gullotti

  • 1Giovanni Fazio, Maria Giovino, Alessandro Gullotti, Daniela Bacarella, Giuseppina Novo, Salvatore Novo, Division of Cardiology, University of Palermo, 90100, Palermo, Italy.

World Journal of Cardiology
|December 17, 2010
PubMed

Insights

Coronary atherosclerosis, a leading cause of death, involves complex pathological processes including inflammation and thrombosis. This review explores these mechanisms and the potential role of Chlamydia infection.

Area of Science:

  • Cardiovascular Pathology
  • Infectious Disease Immunology

Background:

  • Coronary heart disease is a major cause of mortality globally.
  • Coronary atherosclerosis underlies most ischemic heart disease and acute coronary syndromes.
  • Plaque disruption and thrombosis are key events in acute coronary syndromes.

Purpose of the Study:

  • To review the pathological processes involved in atherosclerosis.
  • To discuss the potential role of Chlamydia infection in atherosclerosis and phlogosis.

Main Methods:

  • Literature review of pathological mechanisms in atherosclerosis.
  • Discussion of inflammatory, proliferative, degenerative, and thrombotic processes.
  • Exploration of Chlamydia's potential contribution to phlogosis.

Main Results:

  • Atherosclerosis results from a complex interplay of endothelial dysfunction, lipid accumulation, inflammation, smooth muscle cell proliferation, and thrombosis.
  • Calcification/ossification may be an active pathological process.
  • Chlamydia infection is investigated for its potential role in exacerbating these processes.

Conclusions:

  • Understanding the multifaceted pathology of atherosclerosis is crucial for developing effective treatments.
  • Further research is warranted to elucidate the specific contribution of Chlamydia infection to coronary atherosclerosis and phlogosis.

Keywords:
ChlamydiaCoronary atherosclerosisCoronary heart diseasePhlogosis

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...